Bainom

Bainom is an early-stage biotech startup founded in 2019 and headquartered in the United States. The company's slogan - "Unlocking clinical insights by decoding intricate multi-omic patterns" - encapsulates its core mission. Bainom specializes in developing an innovative artificial intelligence (AI) and machine learning (ML) driven bioinformatics platform, with a focus on making actionable multi-omic data and its inference accessible to all. The startup's platform is oriented towards systems biology and has significant applications in drug discovery, precision health, and biomedical research. It boasts the largest collection of cloud-based AI/ML bioinformatic workflows, unique multi-omic data silos, deep mining of all available -omics dataspace, and dynamic visualization of inferred patterns. Moreover, Bainom leverages its interdisciplinary computational/experimental biology experience to identify and validate previously unknown biomarkers and druggable targets for difficult-to-treat and rare diseases. Bainom's recent milestone is receiving a Pre Seed Round investment from XLerateHealth on 02 August 2022. The startup's vision is to transform the therapeutics of difficult-to-treat diseases and accelerate the discovery of new treatments through AI/ML driven solutions that unlock the full clinical potential of multi-omic data. With a focus on Analytics, Big Data, and Biotechnology, Bainom stands at the forefront of leveraging advanced technologies to drive innovation in the biotech industry.